ADT Inc. (NYSE:ADT) is among the 13 Most Undervalued Stocks Under $20 to Buy. On November 4, the company reported financial ...

ADT Inc. (NYSE:ADT) is one of the best cheap stocks under $10 to buy now. Barclays analyst Manav Patnaik maintained a Hold ...

ADT reported higher Q3 earnings and cash flow driven by ADT+ adoption and operational discipline, even as attrition edged up ...

Phase 3 ARENSENS clinical trial results were presented at JADPRO 2025, indicating darolutamide plus ADT improved rPFS in prostate cancer.

Virginia Giuffre's memoir reveals intimate details about her family life, children Omaha Steaks CEO warns American families ...

Sonepur: Vigilance sleuths Friday arrested Subarnapur Assistant Director of Textiles (ADT) and in-charge Deputy Director of ...

Is facial recognition the future of home security? With ADT’s Trusted Neighbor feature, you can provide controlled, ...

Google’s home security partner, ADT, has a big discount available for anyone looking to start off a new security ...

Continued strong financial results and cash generation Revenue, up 4% versus prior year, driven by durable recurring monthly ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

ADT expects full-year earnings in the range of 85 cents to 89 cents per share, with revenue in the range of $5.08 billion to $5.18 billion. ADT shares have risen 27% since the beginning of the year, ...

Discover ADT’s Q3 2025 earnings highlights: strong revenue growth, AI-driven efficiency, and confident outlook.